Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Dive

Showing results (201-210 of 207) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 207 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2016
Consensus on precision medicine for metastatic cancers: a report from the MAP conferenceC Swanton, J-C Soria, A Bardelli, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2019
Novel phase I trial design to evaluate the addition of cediranib or selumetinib to preoperative chemoradiotherapy for locally advanced rectal cancer: the DREAMtherapy trialF E Marti Marti, G C Jayson, P Manoharan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2016
Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case studyC J Morrow, F Trapani, R L Metcalf, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2019
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancerC R Lindsay, F H Blackhall, A Carmel, et al.
Investigational New Drugs|April 30, 2015
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studiesA Omlin, R J Jones, R van der Noll, et al.
ESMO Open|January 5, 2021
Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcomeR J Lee, O Wysocki, T Bhogal, et al.
ESMO Open|February 5, 2021
Erratum to 'Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome': [ESMO Open Volume 6, Issue 1, February 2021, 100005]R J Lee, O Wysocki, T Bhogal, et al.
Pageof 21

Showing results (201-210 of 207) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 207 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2016
Consensus on precision medicine for metastatic cancers: a report from the MAP conferenceC Swanton, J-C Soria, A Bardelli, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2019
Novel phase I trial design to evaluate the addition of cediranib or selumetinib to preoperative chemoradiotherapy for locally advanced rectal cancer: the DREAMtherapy trialF E Marti Marti, G C Jayson, P Manoharan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2016
Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case studyC J Morrow, F Trapani, R L Metcalf, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2019
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancerC R Lindsay, F H Blackhall, A Carmel, et al.
Investigational New Drugs|April 30, 2015
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studiesA Omlin, R J Jones, R van der Noll, et al.
ESMO Open|January 5, 2021
Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcomeR J Lee, O Wysocki, T Bhogal, et al.
ESMO Open|February 5, 2021
Erratum to 'Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome': [ESMO Open Volume 6, Issue 1, February 2021, 100005]R J Lee, O Wysocki, T Bhogal, et al.
Pageof 21